Middle East & Africa Crispr-Based Gene Editing Market Size & Outlook
The crispr-based gene editing market in Middle East & Africa is expected to reach a projected revenue of US$ 205.6 million by 2033. A compound annual growth rate of 11.6% is expected of Middle East & Africa crispr-based gene editing market from 2026 to 2033.
- Biotechnology
- Genomics & Genetic Engineering
- CRISPR-based Gene Editing Market Outlook
- Genomics & Genetic Engineering
Revenue, 2025 (US$M)
$86.7
Estimate, 2026 (US$M)
$95.5
Forecast, 2033 (US$M)
$205.6
CAGR, 2026 - 2033
11.6%
Global Market
Related Markets
Ask Prism AI anything about the crispr-based gene editing market
Get a cited answer from GVR research in seconds: segment shares, growth drivers, regulation and forecast assumptions.
Every answer starts with GVR research, and every figure is cited.Explore Prism AI
MEA crispr-based gene editing market highlights
- The MEA crispr-based gene editing market generated a revenue of USD 86.7 million in 2025.
- The market is expected to grow at a CAGR of 11.6% from 2026 to 2033.
- In terms of segment, product was the largest revenue generating type in 2025.
- Service is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, Saudi Arabia is expected to register the highest CAGR from 2026 to 2033.
MEA data book summary
| Market revenue in 2025 | USD 86.7 million |
| Market revenue in 2033 | USD 205.6 million |
| Growth rate | 11.6% (CAGR from 2026 to 2033) |
| Largest segment | Product |
| Fastest growing segment | Service |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Product, Service |
| Key market players worldwide | Revvity Inc, Danaher Corp, Genscript Biotech Corp Class H, Merck KGaA, Thermo Fisher Scientific, Inc., Bio-Techne Corp, Origene Technologies, Bio-Rad Laboratories Inc Class A, New England Biolabs |
Other key industry trends
- In terms of revenue, MEA region accounted for 1.9% of the global crispr-based gene editing market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 3,558.5 million by 2033.
No credit card required*
Publish Date: Jun 12, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
CRISPR-Based Gene Editing Market Scope
CRISPR-based Gene Editing Market segmentation & scope
CRISPR-Based Gene Editing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Merck KGaA | View profile | 62,345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | www.emdgroup.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| Revvity Inc | View profile | 11,500 | 940 Winter Street, Waltham, MA, United States, 02451 | www.revvity.com |
| Bio-Techne Corp | View profile | 3,050 | 614 McKinley Place N.E., Minneapolis, MN, United States, 55413 | www.bio-techne.com |
| Genscript Biotech Corp Class H | View profile | 6,937 | No. 28, Yongxi Road, Jiangning Science Park, Jiangsu Province, Nanjing, China, People's Republic of, 211100 | www.genscript.com |
| New England Biolabs | View profile | 501-1000 | Ipswich, Massachusetts, United States, North America | neb.com |
| Origene Technologies | View profile | 501-1000 | Rockville, Maryland, United States, North America | www.origene.com |
| Bio-Rad Laboratories Inc Class A | View profile | 8,030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | www.bio-rad.com |
| Thermo Fisher Scientific, Inc. | View profile | - | - | - |
Middle East & Africa CRISPR-based Gene Editing Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to CRISPR-based Gene Editing Market Outlook will help companies and investors design strategic landscapes.
Product was the largest segment with a revenue share of 80.62% in 2025.
Horizon Databook has segmented the Middle East & Africa crispr-based gene editing market based on product, service covering the revenue growth of each sub-segment from 2021 to 2033.
- Middle East & Africa Crispr-Based Gene Editing Market Type Outlook (Revenue, USD Million , 2021-2033)
- Product
- Service
- Middle East & Africa Crispr-Based Gene Editing Market Application Outlook (Revenue, USD Million , 2021-2033)
- Biomedical
- Agricultural Applications
- Middle East & Africa Crispr-Based Gene Editing Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Contract Research Organizations
Reasons to subscribe to CRISPR-based Gene Editing Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of CRISPR-based Gene Editing Market Outlook databook
- Our clientele includes a mix of CRISPR-based Gene Editing Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa CRISPR-based Gene Editing Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa CRISPR-based Gene Editing Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Middle East Africa Crispr-Based Gene Editing Market, 2021-2033 (US$M)
MEA crispr-based gene editing market statistics, by type, 2021-2033 (US$M)
